XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share - Computation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator:                
Net loss $ (8,129) $ (16,943) $ (15,520) $ (14,110) $ (23,824) $ (18,223) $ (40,592) $ (56,157)
Net loss attributable to noncontrolling interest 15     38     58 103
Net loss attributable to Barinthus Biotherapeutics plc shareholders $ (8,114)     $ (14,072)     $ (40,534) $ (56,054)
Denominator:                
Weighted-average ordinary shares outstanding, basic (in shares) 39,419,447     38,533,833     39,079,259 38,320,208
Weighted-average ordinary shares outstanding, diluted (in shares) 39,419,447     38,533,833     39,079,259 38,320,208
Net loss per share attributable to ordinary shareholders, basic (in usd per share) $ (0.21)     $ (0.37)     $ (1.04) $ (1.46)
Net loss per share attributable to ordinary shareholders, diluted (in usd per share) $ (0.21)     $ (0.37)     $ (1.04) $ (1.46)